2,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent α-glucosidase and E. coli β-glucuronidase inhibitors

Eur J Med Chem. 2021 Apr 15:216:113322. doi: 10.1016/j.ejmech.2021.113322. Epub 2021 Feb 23.

Abstract

In this paper, the 2,5-disubstituted furan derivatives containing 1,3,4-thiadiazole were synthesized and screened for their inhibitory activity against α-glucosidase and β-glucuronidases to obtain potent α-glucosidase inhibitor 9 (IC50 = 0.186 μM) and E. coli β-glucuronidase inhibitor 26 (IC50 = 0.082 μM), respectively. The mechanisms of the compounds were studied. The kinetic study revealed that compound 9 is a competitive inhibitor against α-glucosidase (Ki = 0.05 ± 0.003 μM) and molecular docking simulation showed several key interactions between 9 and the target including hydrogen bond and p-π stacking interaction. Derivative 26 (Ki = 0.06 ± 0.005 μM) displayed uncompetitive inhibition behavior against EcGUS. Furthermore, the result of docking revealed the furan ring of 26 may be a key moiety in obstructing the active domain of EcGUS. In addition, compound 15 exhibited significant inhibitory activity against these two enzymes, with potential therapeutic effects against diabetes and against CPT-11-induced diarrhea. At the same time, their low toxicity against normal liver tissue LO2 cells lays the foundation for in vivo studies and the development of bifunctional drug.

Keywords: 1,3,4-Thiadiazole; 2,5-Disubstituted furan derivatives; CPT-11-Induced toxicity; Diabetes; E. coli β-glucuronidase; α-Glucosidase.

MeSH terms

  • Binding Sites
  • Catalytic Domain
  • Cell Line
  • Cell Survival
  • Escherichia coli / enzymology*
  • Escherichia coli Proteins / antagonists & inhibitors
  • Escherichia coli Proteins / metabolism
  • Furans / chemistry*
  • Furans / pharmacology
  • Glucuronidase / antagonists & inhibitors
  • Glucuronidase / metabolism
  • Glycoproteins / chemistry*
  • Glycoproteins / pharmacology
  • Glycoside Hydrolase Inhibitors / chemistry*
  • Glycoside Hydrolase Inhibitors / pharmacology
  • Humans
  • Kinetics
  • Molecular Docking Simulation
  • Structure-Activity Relationship
  • Thiadiazoles / chemistry*

Substances

  • Escherichia coli Proteins
  • Furans
  • Glycoproteins
  • Glycoside Hydrolase Inhibitors
  • Thiadiazoles
  • beta-glucuronidase inhibitor
  • 1,3,4-thiadiazole
  • Glucuronidase